Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Gastroenterology
  4. Other

Other

  • Bowel Preps (11)
  • Celiac Disease (4)
  • Constipation (55)
  • Crohn's Disease (6)
  • Diarrhea (55)
  • Gastrointestinal Bleeding (105)
  • GERD (78)
  • Heartburn (16)
  • Hemorrhoids (4)
  • Inflammatory Bowel Disease (10)
  • IBS (18)
  • Liver Disease (102)
  • Nausea & Vomiting (50)
  • Other (101)
  • Peptic Ulcer Disease (48)
  • Resources (110)
  • Ulcerative Colitis (2)
  • Ulcers (7)
61 - 75 of 101 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: more opportunities to help obese patients getting bariatric surgery avoid problems with their meds December 2013
Commentary: Strategies for Lowering Triglycerides December 2013
Article: new warnings about intestinal problems linked to the "ARB" blood pressure med, olmesartan (Benicar, etc) September 2013
Commentary: Olmesartan and Severe Intestinal Problems September 2013
Article: Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of "gliptins" for treating type 2 diabetes August 2013
Article: a renewed push to get prescribers to avoid ORAL diclofenac (Cataflam, Voltaren, etc) for treating inflammation and pain July 2013
Article: Many people assume FDA considers the VALUE of new drugs as part of their drug approval process July 2013
Article: treating "gastroparesis" stomach problems in patients with diabetes June 2013
Article: if enzyme supplements help gas and bloating June 2013
Commentary: Pharmacotherapy of Gastroparesis June 2013
Guideline: Management of Gastroparesis (2013) June 2013
Commentary: Digestive Enzyme Supplements June 2013
Commentary: Managing Antithrombotics Before Minor Procedures May 2013
Other: Managing Antithrombotics Before Minor Procedures May 2013
Article: more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis April 2013
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved